Sublingual immunotherapy, a liquid treatment for allergies taken under the tongue, is becoming...
Sublingual immunotherapy, a liquid treatment for allergies taken under the tongue, is becoming increasingly popular as an alternative to traditional allergy shots. While not yet approved by the FDA, the treatment could be a boon for the company that gets there first, and there are at least three companies, including heavyweight Merck (MRK +1%), that are funding large U.S. studies aimed at getting it approved in the next few years.
From other sites
Video at CNBC.com (Oct 26, 2015)
Video at CNBC.com (Jul 28, 2015)
Video at CNBC.com (Mar 25, 2015)
at CNBC.com (Feb 4, 2015)
Video at CNBC.com (Jan 20, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs